249 related articles for article (PubMed ID: 16404905)
1. [Remote results of the standard ovary cancer treatment].
Ushakov II; Mel'ko AI; Kira EF; Ermolinskiĭ II
Voen Med Zh; 2005 Nov; 326(11):36-8. PubMed ID: 16404905
[No Abstract] [Full Text] [Related]
2. [Therapeutic concept in ovarian cancer].
Rath W; Meden H
Med Klin (Munich); 1991 May; 86(5):263-8. PubMed ID: 1875867
[No Abstract] [Full Text] [Related]
3. Cancer ovary, present and future of management.
Parvez T
J Ayub Med Coll Abbottabad; 2003; 15(2):65-8. PubMed ID: 14552255
[TBL] [Abstract][Full Text] [Related]
4. Treatment of germ cell tumors of the ovary.
Williams SD
Semin Oncol; 1991 Jun; 18(3):292-6. PubMed ID: 1645889
[No Abstract] [Full Text] [Related]
5. The treatment of early stage ovarian cancer.
Young RC
Semin Oncol; 1995 Oct; 22(5 Suppl 12):76-9. PubMed ID: 7481865
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of epithelial ovarian cancer: a review of the literature.
Dupont NC; Berman ML
Minerva Ginecol; 2004 Dec; 56(6):547-56. PubMed ID: 15729207
[TBL] [Abstract][Full Text] [Related]
7. Dysgerminoma of the ovary.
LaPolla JP; Benda J; Vigliotti AP; Anderson B
Obstet Gynecol; 1987 Jun; 69(6):859-64. PubMed ID: 3574816
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant measures after primary surgery of ovarian cancer].
Bauknecht T
Gynakologe; 1994 Apr; 27(2):70-5. PubMed ID: 8039745
[No Abstract] [Full Text] [Related]
9. Synchronous ovarian cancer in a patient with pleomorphic lobular breast cancer: a therapeutic dilemma.
Dizdar O; Arslan C; Altundag K
Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):153-4. PubMed ID: 19864120
[No Abstract] [Full Text] [Related]
10. [Current status of the management of patients with malignant ovarian cancer in Hungary].
Szánthó A; Szabó I; Demeter A; Papp Z
Orv Hetil; 1997 Feb; 138(7):405-11. PubMed ID: 9091841
[TBL] [Abstract][Full Text] [Related]
11. [Malignant ovarian cancer: conservative treatment and quality of life in young patients].
Ivanov S
Akush Ginekol (Sofiia); 2008; 47(5):11-3. PubMed ID: 19227771
[TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy and prognostic significance of the size of the remaining tumor in ovarian cancer].
Petru E; Lahousen M; Pickel H; Stettner H
Gynakol Rundsch; 1989; 29 Suppl 2():413-4. PubMed ID: 2613067
[No Abstract] [Full Text] [Related]
13. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA
Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
[TBL] [Abstract][Full Text] [Related]
14. [Analytical studies on the treatment of adenocarcinoma of the ovary].
Matsumoto Y; Kasamatsu T; Sonoda T; Ohmi K; Tsunematsu R; Tanemura K; Yamada T; Kishi K
Nihon Gan Chiryo Gakkai Shi; 1984 May; 19(4):778-88. PubMed ID: 6491429
[No Abstract] [Full Text] [Related]
15. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
[TBL] [Abstract][Full Text] [Related]
16. Patients with malignancy requiring urgent therapy: CASE 1. Central airway obstruction as first presentation of ovarian cancer.
Tasci S; Kovacs A; Leutner C; Zivanovic O; Lüderitz B; Büttner R; Mey U
J Clin Oncol; 2005 Sep; 23(27):6791-3. PubMed ID: 16170186
[No Abstract] [Full Text] [Related]
17. Ovarian cancer of epithelial origin--an update.
Menczer J
Isr J Med Sci; 1993 Aug; 29(8):477-83. PubMed ID: 8407278
[No Abstract] [Full Text] [Related]
18. Management of early ovarian cancer.
Young RC; Pecorelli S
Semin Oncol; 1998 Jun; 25(3):335-9. PubMed ID: 9633845
[TBL] [Abstract][Full Text] [Related]
19. [Sequence of using the components of combined treatment in stage III and IV ovarian cancer patients and late treatment results].
Zadontseva NS
Vopr Onkol; 1985; 31(7):68-72. PubMed ID: 4024563
[TBL] [Abstract][Full Text] [Related]
20. Survival after secondary cytoreduction for recurrent ovarian cancer: which are the prognostic factors?
Biliatis I; Haidopoulos D; Rodolakis A; Vlachos G; Protopapas A; Thomakos N; Sergentanis T; Akrivos N; Antsaklis A
J Surg Oncol; 2010 Nov; 102(6):671-5. PubMed ID: 20721960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
